At the molecular tumor board treatment options and clinical trial participation opportunities for patients with advanced or rare tumors are assessed based on molecular profiling results.
At the molecular tumor board treatment options and clinical trial participation opportunities for patients with advanced or rare tumors are assessed based on molecular profiling results.